Dolby Laboratories (DLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 06-2008 | 03-2008 | 12-2007 | 09-2007 | 06-2007 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 369,907 | 347,502 | 280,246 | 368,467 | 325,909 |
| Marketable Securities | 49,552 | 28,905 | 200,727 | 231,217 | 210,548 |
| Receivables | 45,933 | 43,399 | 37,955 | 28,165 | 45,896 |
| Inventories | 22,000 | 20,153 | 14,585 | 14,883 | 14,091 |
| Income taxes - deferred | 85,576 | 81,874 | 76,086 | 73,686 | 57,831 |
| TOTAL | $619,986 | $549,429 | $629,184 | $733,418 | $668,094 |
| Non-Current Assets | |||||
| PPE Net | 85,775 | 84,565 | 85,079 | 85,552 | 81,457 |
| Investments And Advances | 179,538 | 165,880 | 29,301 | 73,224 | 80,047 |
| Intangibles | 364,303 | 366,405 | 352,639 | 74,753 | 74,936 |
| Other Non-Current Assets | 26,005 | 24,989 | 30,428 | 24,750 | 19,166 |
| TOTAL | $655,621 | $641,839 | $497,447 | $258,279 | $255,606 |
| Total Assets | $1,275,607 | $1,191,268 | $1,126,631 | $991,697 | $923,700 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,607 | 1,591 | 1,571 | 1,563 | 1,528 |
| Accounts payable and accrued liabilities | 143,312 | 131,006 | 138,488 | 9,281 | 103,223 |
| Accrued Expenses | N/A | N/A | N/A | 109,787 | N/A |
| TOTAL | $178,646 | $159,260 | $173,572 | $143,204 | $122,911 |
| Non-Current Liabilities | |||||
| Long Term Debt | 8,408 | 8,810 | 9,209 | 9,691 | 10,037 |
| Deferred Revenues | 30,894 | 24,594 | 18,358 | 13,522 | 11,927 |
| Other Non-Current Liabilities | 52,022 | 51,306 | 54,046 | 36,573 | 36,099 |
| TOTAL | $85,484 | $84,338 | $85,881 | $51,337 | $57,520 |
| Total Liabilities | $264,130 | $243,598 | $259,453 | $194,541 | $180,431 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 112,251 | 111,590 | 111,046 | 110,386 | 110,005 |
| Common Shares | 113 | 112 | 111 | 110 | 110 |
| Retained earnings | 560,936 | 514,488 | 457,710 | 409,749 | 365,591 |
| Other shareholders' equity | 25,926 | 25,471 | 16,358 | 11,467 | 11,661 |
| TOTAL | $1,011,477 | $947,670 | $867,178 | $797,156 | $743,269 |
| Total Liabilities And Equity | $1,275,607 | $1,191,268 | $1,126,631 | $991,697 | $923,700 |